We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$162M
Cap. Flow
+$72.6M
Cap. Flow %
25.66%
Top 10 Hldgs %
42.53%
Holding
215
New
70
Increased
65
Reduced
14
Closed
66

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$2.38M
2
WMT icon
Walmart Inc
WMT
+$2.38M
3
JPM icon
JPMorgan Chase
JPM
+$2.13M
4
FATE icon
Fate Therapeutics
FATE
+$1.92M
5
FTNT icon
Fortinet
FTNT
+$1.5M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.05M
2
PFE icon
Pfizer
PFE
+$1.44M
3
CVS icon
CVS Health
CVS
+$1.41M
4
MET icon
MetLife
MET
+$1.4M
5
DE icon
Deere & Co
DE
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Technology 15.05%
3 Industrials 8.12%
4 Healthcare 7.38%
5 Energy 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBTX
126
DELISTED
Veritex Holdings
VBTX
$1.02M 0.36%
+36,150
New +$1.07M
TITN icon
127
Titan Machinery
TITN
$438M
$1.01M 0.36%
25,514
+6,498
+34% +$231K
TEN
128
Tsakos Energy Navigation Ltd
TEN
$1.15B
$1.01M 0.36%
+59,728
New +$1.05M
SYBT icon
129
Stock Yards Bancorp
SYBT
$2.6B
$996K 0.35%
+15,322
New +$1.1M
UPS icon
130
United Parcel Service
UPS
$88.8B
$994K 0.35%
5,719
-904
-14% -$156K
SENT
131
DELISTED
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
$989K 0.35%
43,807
-1,276
-3% -$29.3K
CCRN
132
DELISTED
Cross Country Healthcare
CCRN
$983K 0.35%
36,981
+18,772
+103% +$613K
WNC icon
133
Wabash National
WNC
$505M
$971K 0.34%
+42,948
New +$932K
FIS icon
134
Fidelity National Information Services
FIS
$22.1B
$953K 0.34%
14,043
+7,062
+101% +$502K
JNJ icon
135
Johnson & Johnson
JNJ
$626B
$947K 0.33%
5,359
+328
+7% +$56.6K
AZO icon
136
AutoZone
AZO
$49.7B
$937K 0.33%
+380
New +$918K
EOG icon
137
EOG Resources
EOG
$75.2B
$910K 0.32%
7,022
-4,804
-41% -$639K
MS icon
138
Morgan Stanley
MS
$338B
$875K 0.31%
10,294
+2,524
+32% +$215K
MDT icon
139
Medtronic
MDT
$116B
$714K 0.25%
9,184
+2,294
+33% +$186K
SPYG icon
140
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
$522K 0.18%
10,306
+1,960
+23% +$102K
IVV icon
141
iShares Core S&P 500 ETF
IVV
$902B
$393K 0.14%
1,023
+18
+2% +$6.95K
TSLA icon
142
Tesla
TSLA
$1.31T
$384K 0.14%
+3,114
New +$590K
RVT icon
143
Royce Value Trust
RVT
$2.3B
$324K 0.11%
+24,400
New +$336K
FIAX icon
144
Nicholas Fixed Income Alternative ETF
FIAX
$129M
$302K 0.11%
+15,133
New +$302K
ESGU icon
145
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
$283K 0.1%
3,345
-138
-4% -$11.8K
SPY icon
146
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$268K 0.09%
+700
New +$269K
IWM icon
147
CALL
iShares Russell 2000 ETF
IWM
$81.8B
$209K 0.07%
+1,200
New +$213K
SPY icon
148
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$160K 0.06%
+419
New +$161K
IWM icon
149
iShares Russell 2000 ETF
IWM
$81.8B
$174 ﹤0.01%
+1
New +$178
ACLS icon
150
Axcelis
ACLS
$4.18B
– –
-8,528
Closed -$516K
4 5
6
7 8

Similar funds

CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
PC
Prysm Capital Princeton, New Jersey $10.6M AUM 2.38% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AVM
Altos Ventures Management Burlingame, California $11.7M AUM 182.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return

Alpha DNA Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpha DNA Investment Management held 215 positions worth $283M, up 135% from $120M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management deployed $72.6M of net new capital in Q4 2022, opening 70 new positions and adding to 65 existing holdings. Its largest new stake was Fate Therapeutics: 102,094 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.05M trimmed.

  • Alpha DNA Investment Management's largest Q4 2022 buy was Fate Therapeutics: 102,094 shares worth $1.03M.
  • Alpha DNA Investment Management added most to McDonald's in Q4 2022, an estimated $2.38M increase.
  • Alpha DNA Investment Management's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $2.05M.
  • Alpha DNA Investment Management fully exited CVS Health in Q4 2022, selling an estimated $1.41M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $283M portfolio in Q4 2022.
  • Alpha DNA Investment Management opened 70 new positions and closed 66 in Q4 2022.
  • Alpha DNA Investment Management's portfolio value rose 135% quarter-over-quarter to $283M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.